Alimentary Pharmacology & Therapeutics

Review article: prebiotics in the gastrointestinal tract
pp. 701-714(14)
Authors: MACFARLANE, S.; MACFARLANE, G. T.; CUMMINGS, J. H.

Review article: thiopurines in inflammatory bowel disease
pp. 715-729(15)
Authors: DERIJKS, L. J. J.; GILISSEN, L. P. L.; HOOYMANS, P. M.; HOMMES, D. W.

Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?
pp. 731-742(12)
Authors: PANOS, G. Z.; BETSI, G. I.; FALAGAS, M. E.

Systematic review: proton pump inhibitors (PPIs) for the healing of reflux oesophagitis - a comparison of esomeprazole with other PPIs
pp. 743-750(8)
Authors: EDWARDS, S. J.; LIND, T.; LUNDELL, L.

Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs
pp. 751-767(17)
Authors: LAINE, L.; SMITH, R.; MIN, K.; CHEN, C.; DUBOIS, R. W.

Systematic review: the effectiveness of hypnotherapy in the management of irritable bowel syndrome
pp. 769-780(12)
Authors: WILSON, S.; MADDISON, T.; ROBERTS, L.; GREENFIELD, S.; SINGH, S.

Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis
pp. 781-788(8)
Authors: FABRIZI, F.; DIXIT, V.; MARTIN, P.

Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease
pp. 789-796(8)
Authors: FABRIZI, F.; GANESHAN, S. V.; DIXIT, V.; MARTIN, P.

Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C
pp. 797-804(8)
Authors: BORRONI, G.; CERIANI, R.; CAZZANIGA, M.; TOMMASINI, M.; RONCALLI, M.; MALTEMPO, C.; FELLINE, C.; SALERNO, F.

Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent
pp. 805-811(7)
Authors: BERENDS, M. A. M.; SNOEK, J.; DE JONG, E. M. G. J.; VAN DE KERKHOF, P. C. M.; VAN OIJEN, M. G. H.; VAN KRIEKEN, J. H.; DRENTH, J. P. H.

Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy
pp. 813-820(8)
Authors: BABATIN, M. A.; SANAI, F. M.; SWAIN, M. G.

Three centuries of stomach symptoms in Scotland
pp. 821-829(9)
Authors: BARON, J. H.; WATSON, F.; SONNENBERG, A.

Stability of E-cadherin methylation status in gastric mucosa associated with histology changes
pp. 831-836(6)
Authors: CHAN, A. O. O.; HUANG, C.; HUI, W. M.; CHO, C. H.; YUEN, M. F.; LAM, S. K.; RASHID, A.; WONG, B. C.-Y.

Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial
pp. 837-843(7)
Authors: YE, B. D.; CHEON, J. H.; CHOI, K. D.; KIM, S. G.; KIM, J. S.; JUNG, H. C.; SONG, I. S.

Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection
pp. 845-850(6)
Authors: GRAHAM, D. Y.; ABUDAYYEH, S.; EL-ZIMAITY, H. M. T.; HOFFMAN, J.; REDDY, R.; OPEKUN, A. R.

Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions
pp. 851-858(8)
Authors: DUBURQUE, C.; LELONG, J.; IACOB, R.; SEDDIK, M.; DESREUMAUX, P.; FOURNIER, C.; WALLAERT, B.; CORTOT, A.; COLOMBEL, J.-F.

Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers
pp. 859-867(9)
Authors: TALLEY, N. J.; CAMILLERI, M.; BURTON, D.; THOMFORDE, G.; KOCH, K.; RUCKER, M. J.; PETERSON, J.; ZINSMEISTER, A. R.; EARNEST, D. L.

A patient follow-up survey programme for alosetron: assessing compliance to and effectiveness of the risk management programme
pp. 869-878(10)
Authors: MILLER, D.; BENNETT, L.; HOLLIS, K.; TENNIS, P.; COOK, S.; ANDREWS, E.

Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database
pp. 879-886(8)
Authors: JONES, R.; LATINOVIC, R.; CHARLTON, J.; GULLIFORD, M.

Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients
pp. 887-894(8)
Author: ROSSIGNOL, J.-F.

Corrigendum
pp. 895-895(1)